05.01.2026

The Hidden Repertoire: Neoself-Antigens in Lupus and Cancer

Antigen Alithea Bio

Immune cells in Lupus target neoself-antigens!

Neoself antigens are parts of a normal protein that are naturally NOT presented on HLA complexes, but due to dysregulation in disease, such as after EBV infection, get presented.
HLA-peptide presentation is also dysregulated in cancer.

We see this daily in our HLA-peptide database HLA-Compass. We have identified thousands of peptides that are specifically presented in cancer tissues, but not on healthy cells, representing potential targets for precisionmedicine.

immunopeptidomics Tcells cellandgenetherapy

Read more

7th-TCR-Based-Therapies-Summit-logo-1-scaled-1.webp Aliteha bio

Alithea Bio to Join Industry Leaders at the 7th TCR-Based Therapies Summit in Boston

Read
Alisa Fuchs, PhD, German Innovation Award 2026

Alithea Bio Receives German Innovation Award 2026 for HLA-Compass Platform

Read
HLA binding prediction tool HLA-Compass AI Alithea Bio deep learning immunopeptidomics

HLA Binding Prediction: How Alithea Bio Outperforms MHCflurry 2.0

Read